Publication | Open Access
Efficacy of Osimertinib Plus Bevacizumab vs Osimertinib in Patients With <i>EGFR</i> T790M–Mutated Non–Small Cell Lung Cancer Previously Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
178
Citations
17
References
2021
Year
UMIN Clinical Trials Registry Identifier: UMIN000023761.
| Year | Citations | |
|---|---|---|
Page 1
Page 1